These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32699802)

  • 1. Diagnosis of TIO: Is Serum FGF23 Measurement always the Answer?
    Ramakrishnan A; Kannan S; Warrier R; Nadig MR; Zaidi SN; Kudari A
    Indian J Endocrinol Metab; 2020; 24(2):230-231. PubMed ID: 32699802
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
    Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO).
    Kinoshita Y; Takashi Y; Ito N; Ikegawa S; Mano H; Ushiku T; Fukayama M; Nangaku M; Fukumoto S
    Bone Rep; 2019 Jun; 10():100192. PubMed ID: 30627598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant.
    Shiba E; Matsuyama A; Shibuya R; Yabuki K; Harada H; Nakamoto M; Kasai T; Hisaoka M
    Diagn Pathol; 2016 Mar; 11():26. PubMed ID: 26956379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.
    Bahrami A; Weiss SW; Montgomery E; Horvai AE; Jin L; Inwards CY; Folpe AL
    Am J Surg Pathol; 2009 Sep; 33(9):1348-54. PubMed ID: 19609206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
    Imel EA; Peacock M; Pitukcheewanont P; Heller HJ; Ward LM; Shulman D; Kassem M; Rackoff P; Zimering M; Dalkin A; Drobny E; Colussi G; Shaker JL; Hoogendoorn EH; Hui SL; Econs MJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2055-61. PubMed ID: 16551733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the half-life of serum fibroblast growth factor 23.
    Hana T; Tanaka S; Nakatomi H; Shojima M; Fukumoto S; Ikemura M; Saito N
    Endocr J; 2017 Oct; 64(10):1033-1039. PubMed ID: 28768937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
    Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6500-5. PubMed ID: 11344269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease.
    Hu F; Jiang C; Zhang Q; Shi H; Wei L; Wang Y
    Dis Markers; 2016; 2016():3176978. PubMed ID: 27034530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases.
    Feng J; Jiang Y; Wang O; Li M; Xing X; Huo L; Li F; Yu W; Zhong DR; Jin J; Liu Y; Qi F; Lv W; Zhou L; Meng XW; Xia WB
    Endocr J; 2017 Jul; 64(7):675-683. PubMed ID: 28450684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
    Weber TJ; Liu S; Indridason OS; Quarles LD
    J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-induced osteomalacia.
    Florenzano P; Gafni RI; Collins MT
    Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors.
    Carter JM; Caron BL; Dogan A; Folpe AL
    Am J Surg Pathol; 2015 Jan; 39(1):75-83. PubMed ID: 25025444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor-induced osteomalacia caused by an FGF23-secreting myopericytoma : Case report and literature review].
    Muro Bushart N; Tharun L; Oheim R; Paech A; Kiene J
    Orthopade; 2020 Jan; 49(1):1-9. PubMed ID: 30937490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment.
    Endo I; Fukumoto S; Ozono K; Namba N; Inoue D; Okazaki R; Yamauchi M; Sugimoto T; Minagawa M; Michigami T; Nagai M; Matsumoto T
    Endocr J; 2015; 62(9):811-6. PubMed ID: 26135520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia.
    Zhang Q; Doucet M; Tomlinson RE; Han X; Quarles LD; Collins MT; Clemens TL
    Bone Res; 2016; 4():16011. PubMed ID: 27468359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
    Kinoshita Y; Fukumoto S
    Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor-induced Hypophosphatemic Osteomalacia Caused by a Chest Wall Tumor].
    Kin Y; Ogawa H; Matsumoto G; Mitsui S; Matsumoto T; Nishioka Y; Sakai S; Kimura K; Shimizu N; Hokka D; Tanaka Y; Maniwa Y
    Kyobu Geka; 2019 Aug; 72(8):570-573. PubMed ID: 31353346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.